Grants and Contributions:
Title:
Development of novel feedstock additives to combat diseases in farmed shrimp - proof of concept
Agreement Number:
958358
Agreement Value:
$700,000.00
Agreement Date:
Sep 1, 2020 - Jun 30, 2022
Description:
Based on NovoBind's novel single-chain antibody fragment (nanobody) technology, the goal of this project is the development and in vivo proof-of-concept of engineered nanobodies to be used as a feed additive to reduce or eliminate Vibrio and White Spot Syndrome Virus infections in the gastrointestinal tract of farmed shrimp.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6E 0C3
Reference Number:
172-2020-2021-Q3-958358
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
843602244
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 250,000 dollars.
Amendment Date
Dec 14, 2021
Recipient's Legal Name:
NovoBind Livestock Therapeutics Inc
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
115210
Amendments: